Oncology

An investigational agent, lenvatinib, has shown favorable activity when compared with a placebo with high response rates and delayed disease progression….

A look at whether type 2 diabetes patients with severe hypoglycemia exhibit certain phenotypes that may predict premature death and all-site cancer….

Out-of-control diabetes may not only put patients at risk of diabetes-related complications but also decrease chances of surviving cancer…. 

An analysis of 25 population studies which focused on weight and included 4 million women, 16,000 of whom developed ovarian cancer. The report showed a dose-response relationship: a six percent increased risk of developing ovarian cancer for every 5-point increase in BMI….

U.S. and European regulators have found no compelling evidence of a link between the drug class which includes GLP-1 analogs and DPP-4 inhibitors, and pancreas problems or pancreatic cancer…. 

But for those over 65, a higher protein intake may be beneficial….

Researchers looked at whether exposure to metformin is associated with a decreased risk of bladder cancer…. 

Drug has demonstrated direct antitumor activity in mouse models…. 

Zinc may increase the levels of a potent cancer fighter in the body…. 

Post market study results….